An in-depth study of the role of MCP-1/CCR2 axis in the inflammatory response and complex immune cell signaling network may provide new ideas for treating renal fibrosis, benefiting an increasing number of patients with CKD. This evidence concerns the gene CCL2 and chronic kidney disease.